Patents by Inventor David Engers

David Engers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CONDUCTIVE TEXTILES
    Publication number: 20210388532
    Abstract: A method of producing electrically conductive metallic structures in or on textiles, which has the following steps: (a) introducing at least one non-conducting precursor compound into a fibre or yarn material during or after the production thereof, wherein the at least one precursor compound is an inorganic metal phosphate compounds, a metal oxide or a spinel of the general formula AB2O4, (b) producing a textile from the fibre or yarn material, (c) irradiating the textile with electromagnetic radiation, preferably with laser light in the regions of the electrically conductive structures to be produced, with the release of metallisation seeds, and (d) electrical or non-electrical treatment of the textile with deposit of metals at the metallisation seeds with the production of conductive structures in the textile.
    Type: Application
    Filed: September 26, 2019
    Publication date: December 16, 2021
    Applicant: Chemische Fabrik Budenheim KG
    Inventors: David ENGERS, Thomas FUTTERER, Tobias MOSS, Gideon RATH, Rüdiger WISSEMBORSKI
  • Method for the manufacture of Fe(II)P/Fe(II)MetP compounds
    Patent number: 10793437
    Abstract: A method for the manufacture of crystal water-free iron(II) orthophosphate of the general formula Fe3(PO4)2 or crystal water-free iron(II) metal orthophosphate, iron(II) metal pyrophosphate or iron(II) metal metaphosphate of the general formula FeaMetb(POc)d, where a is a number from 1 to 5, b is a number from >0 to 5, c is a number from 2.5 to 5, d is a number from 0.5 to 3 and Met represents one or more metals selected from the group consisting of K, Rb, Cs, Mg, Ca, Sr, Ba, the transition metals (d block), in particular Sc, Y, La, Ti, Zr, Hf, Nb, Ta, Cr, Mo, W, Mn, Cu, Zn and the metals and semimetals of the third, fourth and fifth main groups, in particular B, Al, Ga, In, Si, Sn, Sb, Bi and the lanthanoids.
    Type: Grant
    Filed: March 26, 2018
    Date of Patent: October 6, 2020
    Assignee: Chemische Fabrik Budenheim KG
    Inventors: Joachim Adolf, Dominik Braun, Gerhard Eich, David Engers, Bastian Ewald, Christian Litterscheid, Rüdiger Wissemborski
  • METHOD FOR THE MANUFACTURE OF Fe(II)P/Fe(II)MetP COMPOUNDS
    Publication number: 20200095127
    Abstract: A method for the manufacture of crystal water-free iron(II) orthophosphate of the general formula Fe3(PO4)2 or crystal water-free iron(II) metal orthophosphate, iron(II) metal pyrophosphate or iron(II) metal metaphosphate of the general formula FeaMetb(POc)d, where a is a number from 1 to 5, b is a number from >0 to 5, c is a number from 2.5 to 5, d is a number from 0.5 to 3 and Met represents one or more metals selected from the group consisting of K, Rb, Cs, Mg, Ca, Sr, Ba, the transition metals (d block), in particular Sc, Y, La, Ti, Zr, Hf, Nb, Ta, Cr, Mo, W, Mn, Cu, Zn and the metals and semimetals of the third, fourth and fifth main groups, in particular B, Al, Ga, In, Si, Sn, Sb, Bi and the lanthanoids.
    Type: Application
    Filed: March 26, 2018
    Publication date: March 26, 2020
    Applicant: Chemische Fabrik Budenheim KG
    Inventors: Joachim ADOLF, Dominik BRAUN, Gerhard EICH, David ENGERS, Bastian EWALD, Christian LITTERSCHEID, Rüdiger WISSEMBORSKI
  • DISPERSIONS OF RASAGILINE CITRATE
    Publication number: 20140194510
    Abstract: The subject invention provides a solid dispersion of rasagiline citrate, a composition and a process for the manufacture thereof.
    Type: Application
    Filed: March 10, 2014
    Publication date: July 10, 2014
    Applicant: Teva Pharmaceutical Industries Ltd.
    Inventors: Keith Lorimer, David Engers
  • Dispersions of rasagiline citrate
    Patent number: 8691872
    Abstract: The subject invention provides a solid dispersion of rasagiline citrate, a composition and a process for the manufacture thereof.
    Type: Grant
    Filed: July 27, 2011
    Date of Patent: April 8, 2014
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Keith Lorimer, David Engers
  • ROMIDEPSIN SOLID FORMS AND USES THEREOF
    Publication number: 20120190817
    Abstract: The present disclosure provides solid forms of a compound of formula I. In some embodiments, the present disclosure provides crystalline forms of Compound I. In some embodiments, the present disclosure provides solvate forms of Compound I. In some embodiments, the present disclosure provides amorphous Compound I.
    Type: Application
    Filed: July 12, 2011
    Publication date: July 26, 2012
    Applicant: Celgene Corporation
    Inventors: Jason Hanko, David Engers, Eric Hagen, Valeriya Smolenskaya, Jeffrey Stults
  • DISPERSIONS OF RASAGILINE CITRATE
    Publication number: 20120059058
    Abstract: The subject invention provides a solid dispersion of rasagiline citrate, a composition and a process for the manufacture thereof.
    Type: Application
    Filed: July 27, 2011
    Publication date: March 8, 2012
    Inventors: Keith Lorimer, David Engers